期刊文献+

产后出血921例临床分析 被引量:6

Clinical analysis of 921 cases of postpartum hemorrhage
下载PDF
导出
摘要 目的分析产后出血原因为降低和预防产后出血提供参考。方法对本院2009年7月1日至2012年7月31日期间产后出血921例临床资料进行回顾性分析,比较每年产后出血的发生率及产后出血相关因素的变化。结果 2010年与2009年7—12月间产后出血比较阴道分娩的差异有统计学意义,剖宫产差异有显著性,2012年1—7月与2011年产后出血比较阴道分娩无统计学意义,剖宫产差异有显著性。随着每年产数的增加,产后出血病例也有逐年上升趋势,产后出血原因中除胎盘因素和宫缩乏力外,33.33%病例有产科合并症或并发症,有34.53%的产后出血病人产前用普贝生促宫颈成熟或缩宫素引产。结论产后出血是多种原因和多种危险因素所致:加强高危孕产妇管理,积极控制并发症的发生,及早充分认识、重视及预防导致产后出血的高危因素,对预防产后出血有重要意义。 Objective To analyze the reasons of postpartum hemorrhage for reference of reduction and prevention. Methods From July 1st, 2009 to July 31st, 2012in our hospital, 921 cases of postpartum hemorrhage were analyzed retrospectively, compared each year postpartum hemorrhage rate and related factors of postpartum hemorrhage. Results In 2010 and 2009, for the data from July' to December, for postpartum hemorrhage compared with vaginal delivery of the differences were statistically significant, cesarean section and there were significant differences; between 2012 and 2011, from January to July, the data of postpartum hemorrhage compared with vaginal delivery were not statistically significant, there was significant difference in cesarean section. With the increase of the number of annual production of postpartum hemorrhage had a rising trend year by bleeding in placenta factors and uterine atony, 33.33% cases with obstetric complications, 34.53% patients with postpartum hemorrhage prenatal process for cervical ripening or oxytocin in lead production. Conclusions Postpartum hemorrhage is caused by a variety of reasons and many risk factors: strengthen the management of high risk gestation to actively control the occurrence of complications, early understand the importance and prevention of postpartum hemorrhage caused by risk factors has an important significance .
作者 卓贞顺
出处 《齐齐哈尔医学院学报》 2013年第2期202-203,共2页 Journal of Qiqihar Medical University
关键词 产后出血 原因 预防 Postpartum hemorrhage Reason Prevention
  • 相关文献

参考文献3

二级参考文献30

  • 1Oyelese Y,Scoria WE,Mamolia R,et al.Postpartum hemorrhage.Obstet Gynecol Clin North Am,2007,34:421-441.
  • 2American Collage of Obstetricians and Gynecologists.ACOG practice bulletin:clinical management guidelines for obstetriciangynecologists number 76,October 2006:postpartum hemorrhage.Obstet Gynecol,2006,108:1039-1047.
  • 3Cohen WR.Hemorrhagic shock in obstetrics.J Perinat Med,2006,34:263-271.
  • 4Elboume DR,Prendiville WJ,Carmli G,et al.Prophylactic use of oxytocin in the third stage of labour.Cochrune Database Syst Rev,2001,(4):CD001808.
  • 5Mc Donald S.Management of the third stage of labor.J Midwifery Womens Health,2007,52:254-261.
  • 6Anderson JM,Etches D.Prevention and management of postpartum hemorrhage.Am Fam Physician,2007,75:875-882.
  • 7Wedisinghe L,Maclood M,Murphy DJ.Use of oxytoein to prevent haemorrhage at caesarean section-a survey of practice in the United Kingdom.Eur J Obstet Gynocol Reprod Bid,2008,137:27-30.
  • 8Lamont RF,Morgan DJ,Logue M,et al.A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum hacmorrhage.Prostaglandins Other Lipid Mediat,2001,66:203-210.
  • 9Gulmezaglu AM,Foma F,Villar J,et al.Prostaglandins for preventing postpartum hacmorrhage.Cochrane Database Syst Rev,2007,18:CD000494.
  • 10Dabelea V,Schultze PM,McDuffie RS.Intrauterine balloon tampenade in the management of postpartum hemorrhage.Am J Perinatol,2007,24:359-364.

共引文献808

同被引文献37

  • 1Smith JM, Gubin R, Holston MM, et al. Misoprostol for post- partum hemorrhage prevention at home birth:an integrative review of global implementation experience to date[J].BMC Pregnancy Childbirth, 2013,13: 44.
  • 2Odent M. Preventing postpartum haemorrhage [J].Midwifery Today Int Midwife, 2013,(15): 18-19.
  • 3Wetta LA, Szychowski JM, Seals S, et al. Risk factors for u- terine atony/postpartum hemorrhage requiring treatment after vaginal delivery[J]. Am J Obstet Gynecol, 2013, 209(1): 51. e1-51.e6.
  • 4Winiewski K, Finnman J, Flipo M, et al. On the mechanism of degradation of oxytocin and its analogues in aqueous solu- tion[J]. Biopolymers, 2013, 100(4): 408-421.
  • 5A1-Sawaf A, E1-Mazny A, Shohayeb A. A randomised con- trolled trial of sublingual misoprostol and intramuscular oxy- tocin for prevention of postpartum haemorrhage[J]. J Obstet Gynaecol, 2013, 33(3): 277-279.
  • 6Dildy GA. Postpartum hemorrhage: new management options [J] . Clin Obstet Gynecol, 2002, 45 (2) : 330.
  • 7Holm C,Langhoff-Roos J,Petersen KB,et al.Severe postpartum haemorrhage and mode of delivery:a retrospective cohort study[J].BJOG,2012,119(5):596-604.
  • 8Csorba R.Management of post partum haemorrhage[J].Orv Hetil,2012,153(17):643-648.
  • 9Kok N,Kaandorp S,Pajkrt E,et al.Severe postpartum haemorrhage and mode of delivery:a retrospective cohort study[J].BJOG,2012,119(8):1017-1018.
  • 10韩传宝,刘华,于力,陈祖萍,周钦海,钱燕宁.欣母沛用于剖宫产术中不良反应的观察[J].临床麻醉学杂志,2008,24(1):76-77. 被引量:48

引证文献6

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部